The Future of TV Advertising Under RFK

Brought to you by TripleLift and Next In Media

Pharmaceutical advertising has long been one of the biggest cash cows for the TV industry—flooding airwaves with those familiar “ask your doctor” spots featuring happy retirees kayaking their way through life. But what happens if those ads suddenly disappear?

That’s the question tackled in a new report from TVREV Thought Leaders Circle member TripleLift, written by Next In Media’s Mike Shields, which explores the potential impact of a pharma ad ban on TV—an idea that just got a lot more real with Robert F. Kennedy Jr. now confirmed as Secretary of Health and Human Services. RFK Jr. has made it clear he supports banning direct-to-consumer (DTC) pharmaceutical ads on TV, a move that would upend billions in TV ad revenue at a time when the industry is already scrambling to reinvent itself.

A ban like this wouldn’t just be a headache for networks—it would fundamentally reshape TV ad economics, shake up pharma’s marketing playbook, and send ad dollars scrambling to new platforms. So how bad would it be? The new study lays out the numbers, and they aren’t pretty.

Download the full report today - it’s FREE

TVREV

TVREV captures the voices and insights of executives in the TV, digital and advertising industries. Our insights, reports, newsletters, videos and events are guideposts for everyone in the greater television ecosystem, from programmers and distributors to advertisers and adtech companies.

Previous
Previous

The 2025 Advertising & Marketing Report

Next
Next

Stadium to Screen (US Edition)